Uncovering the mode of action of engineered T cells in patient cancer organoidsNature BiotechnologyJuly 25, 202210.1038/s41587-022-01397-wCited by 212SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis